SK Hynix Inc. saw its Seoul-listed shares tumble on Monday following a strong debut of its American Depositary Receipts on the Nasdaq [1, 2].
The volatility highlights a disconnect between the company's immediate capital gains in the U.S. and the long-term caution of investors in its home market. As the company expands its global footprint, the reaction in Seoul suggests a fragile optimism regarding the sustainability of the current memory-chip boom.
The company's Nasdaq debut took place on Friday, July 12, 2026 [6]. During that first day of trading, the ADRs jumped approximately 14% [5]. The listing offered 177.9 million ADRs priced at $149 each, generating total proceeds of about $26.5 billion [3].
Despite the success in New York, the momentum did not carry over to the Korea Exchange. Seoul-listed shares fell on Monday, with reports on the decline ranging from more than 12% [1] to more than 15% [2].
Market analysts said the drop was driven by investors engaging in profit-taking after the U.S. debut. Beyond immediate trading gains, there are growing concerns regarding a potential future oversupply cycle in the semiconductor market [1, 2]. These fears have led to diminishing earnings optimism among traders in Seoul.
SK Hynix, a major South Korean memory-chip maker, remains a critical player in the global supply chain for high-bandwidth memory used in artificial intelligence applications [1, 2]. The sharp correction in Seoul follows the massive capital injection provided by the Nasdaq listing, which now gives the company a substantial war chest for future expansion.
“Seoul-listed shares fell on Monday, with reports on the decline ranging from more than 12% to more than 15%.”
The divergence between SK Hynix's Nasdaq performance and its Seoul listing reflects a common pattern where high-profile U.S. debuts trigger immediate profit-taking in primary markets. More critically, the sell-off indicates that institutional investors are weighing the current AI-driven demand against the historical cyclicality of the semiconductor industry, fearing that a supply glut could erode the earnings growth currently priced into the stock.
